Estradiol 0.5 MG / progesterone 100 MG Oral Capsule [Bijuva] — RxCUI 2632846
RxNorm drug concept · Semantic branded drug
RxCUI 2632846
Semantic branded drug · SBD
● Current RxNorm concept 4 FDA products
7 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI2632846
Official nameEstradiol 0.5 MG / progesterone 100 MG Oral Capsule [Bijuva]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asBijuva 0.5 MG / 100 MG Oral Capsule
FDA products mapped4
Package NDCs mapped7
Reported Medicaid activity (SDUD)2,044 prescriptions · 14 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Progesterone: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- When you still have your uterus and you're taking estrogen, estrogen can cause the lining of your uterus to grow too thick — a condition called endometrial hyperplasia, which can i...
- Why do I need to take progesterone if I'm already on estrogen?
- Yes, and it's important to be honest about this. Large studies have shown that taking estrogen combined with progestin — including progesterone — is associated with a higher risk o...
- Is it true that taking progesterone with estrogen can raise my risk of breast cancer or stroke?
🕸️ Concept Web — How Estradiol 0.5 MG / progesterone 100 MG Oral Caps... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Estradiol 0.5 MG / progesterone 100 MG Oral Capsule [Bijuva]
RxCUI 2632846 Semantic branded drug · SBD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 3
The active substance itself — no strength, form, or brand attached yet.
-
Estradiol
4083IN -
Progesterone
8727IN -
Estradiol / progesterone
815024MIN
-
Estradiol
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Bijuva
2108925BN
-
Bijuva
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Estradiol / progesterone Oral Capsule
2108923SCDF -
Estradiol / progesterone Oral Product
2108921SCDG -
Estradiol / progesterone Pill
2108922SCDG -
Estradiol / progesterone Oral Capsule [Bijuva]
2108927SBDF -
Bijuva Oral Product
2108928SBDG -
Bijuva Pill
2108929SBDG -
Oral Capsule
316965DF -
Oral Product
1151131DFG - +1 more in this family
-
Estradiol / progesterone Oral Capsule
-
Clinical & branded drugs 4
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Estradiol 0.5 MG / progesterone 100 MG Oral Capsule
2632844SCD -
Estradiol 0.5 MG
315880SCDC -
Progesterone 100 MG
317477SCDC -
Estradiol 0.5 MG / progesterone 100 MG [Bijuva]
2632845SBDC
-
Estradiol 0.5 MG / progesterone 100 MG Oral Capsule
Showing up to 8 concepts per family — 16 of 17 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Estradiol 0.5 MG / progesterone 100 MG Oral Capsule
SCD · 2632844 -
Estradiol 0.5 MG
SCDC · 315880 -
Progesterone 100 MG
SCDC · 317477 -
Estradiol / progesterone Oral Capsule
SCDF · 2108923 -
Estradiol / progesterone Oral Product
SCDG · 2108921 -
Estradiol / progesterone Pill
SCDG · 2108922
Brand-Name Concepts
-
Estradiol 0.5 MG / progesterone 100 MG [Bijuva]
SBDC · 2632845 -
Estradiol / progesterone Oral Capsule [Bijuva]
SBDF · 2108927 -
Bijuva Oral Product
SBDG · 2108928 -
Bijuva Pill
SBDG · 2108929 -
Bijuva
BN · 2108925
📦 FDA Products & Package NDCs
4 products · 7 package NDCs
7 package NDCs map to RxCUI 2632846 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 50261-0211-05 | 1 BLISTER PACK in 1 CARTON (50261-211-05) / 5 CAPSULE in 1... | Bijuva | Mayne Pharma LLC | 2019-04-03 |
| 50261-0251-05 | 1 BLISTER PACK in 1 CARTON (50261-251-05) / 5 CAPSULE in 1... | Bijuva | Mayne Pharma LLC | 2023-03-31 |
| 50261-0251-30 | 1 BLISTER PACK in 1 CARTON (50261-251-30) / 30 CAPSULE in 1... | Bijuva | Mayne Pharma LLC | 2023-03-31 |
| 68308-0750-00 | 1 BLISTER PACK in 1 CARTON (68308-750-00) / 5 CAPSULE in 1... | Bijuva | Mayne Pharma | 2023-12-18 |
| 68308-0750-30 | 1 BLISTER PACK in 1 CARTON (68308-750-30) / 30 CAPSULE in 1... | Bijuva | Mayne Pharma | 2023-12-18 |
| 68308-0751-00 | 1 BLISTER PACK in 1 CARTON (68308-751-00) / 5 CAPSULE in 1... | Bijuva | Mayne Pharma | 2023-12-01 |
| 68308-0751-30 | 1 BLISTER PACK in 1 CARTON (68308-751-30) / 30 CAPSULE in 1... | Bijuva | Mayne Pharma | 2023-12-01 |
Observed labelers:
Mayne Pharma (4) ·
Mayne Pharma LLC (3)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.